INNOVADERMA PLC LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
('InnovaDerma' or the 'Company')
Adoption of Share Option Plan and Grant of Share Options
Director/PDMR Shareholding
InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, announces the introduction of a share option plan for the Directors and other management and employees (the 'Share Option Plan') and the initial grant of share options (the 'Options') under the Share Option Plan as further set out below.
The Company considers it important to incentivise employees and Directors through share incentive arrangements and to align them with shareholders to create long term value.
With the introduction of the Share Option Plan, the Board has approved the grant of the Options at an exercise price of £1.20 pence which is approximately 60% higher than the closing mid-market price on the 21st January 2020.The initial grant of 525,000 share options have been awarded to the Directors and a pool of 75,000 share options is to be allocated to other management and employees in due course. These options will vest on the third anniversary of the grant dates subject to the rules of the Share Option Plan and continued employment.
There are no other options in issue and thus following today's grant, the Company has 600,000 options in issue, representing 4.1% of the Company's issued share capital.
Name | Position | Grant of Options | Ordinary Shares currently held |
Joseph John Bayer | Executive Chairman | 250,000 | 161,840 |
Kieran Winston Callan | CEO | 125,000 | 19,300 |
Ross Martin Hilton Andrews | Non-Executive Director | 75,000 | 74,860 |
Rodney David Turner | Non-Executive Director | 75,000 | 51,097 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma Joe Bayer Kieran Callan c/o TB Cardew www.innovaderma.com | +61 (0)3 9863 8030 +44 (0)20 7930 0777 |
finnCapLtd Geoff Nash/ Kate Bannatyne Alice Lane/Manasa Patil - Corporate Broking | +44 (0)207 220 0500 www.finncap.com |
TB Cardew Shan Shan Willenbrock/Tom Allison Olivia Rosser | + 44 (0)20 7930 0777 innovaDerma@tbcardew.com |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||
a) | Name | Joseph John Bayer | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | Executive Chairman | ||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | InnovaDerma PLC | ||||||||
b) | LEI | 213800WRAP6W8VDL6B38 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code |
€0.10 each ordinary share
| ||||||||
b) | Nature of the transaction | Grant of Options under the InnovaDerma PLC Share Option Plan | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information
| 250,000 ordinary shares of €0.10 per ordinary share par value
| ||||||||
e) | Date of the transaction | 22 January 2020 | ||||||||
f) | Place of the transaction | Outside a trading venue |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||
a) | Name | Kieran Winston Callan | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | CEO | ||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | InnovaDerma PLC | ||||||||
b) | LEI | 213800WRAP6W8VDL6B38 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code |
€0.10 each ordinary share
| ||||||||
b) | Nature of the transaction | Grant of Options under the InnovaDerma PLC Share Option Plan | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information
| 125,000 ordinary shares of €0.10 per ordinary share par value
| ||||||||
e) | Date of the transaction | 22 January 2020 | ||||||||
f) | Place of the transaction | Outside a trading venue |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||
a) | Name | Ross Martin Hilton Andrews | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | Non Executive Director | ||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | InnovaDerma PLC | ||||||||
b) | LEI | 213800WRAP6W8VDL6B38 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code |
€0.10 each ordinary share
| ||||||||
b) | Nature of the transaction | Grant of Options under the InnovaDerma PLC Share Option Plan | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information
| 75,000 ordinary shares of €0.10 per ordinary share par value
| ||||||||
e) | Date of the transaction | 22 January 2020 | ||||||||
f) | Place of the transaction | Outside a trading venue |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||
a) | Name | Rodney David Turner | ||||||||
2 | Reason for the notification | |||||||||
a) | Position/status | Non Executive Director | ||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a) | Name | InnovaDerma PLC | ||||||||
b) | LEI | 213800WRAP6W8VDL6B38 | ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a) | Description of the financial instrument, type of instrument Identification code |
€0.10 each ordinary share
| ||||||||
b) | Nature of the transaction | Grant of Options under the InnovaDerma PLC Share Option Plan | ||||||||
c) | Price(s) and volume(s) |
| ||||||||
d) | Aggregated information
| 75,000 ordinary shares of €0.10 per ordinary share par value
| ||||||||
e) | Date of the transaction | 22 January 2020 | ||||||||
f) | Place of the transaction | Outside a trading venue |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Attachments
- Original document
- Permalink
Disclaimer
Innovaderma plc published this content on 23 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 January 2020 09:33:02 UTC
